Concepedia

Elisa Pellegrino

EP

15

Publications

1.1K

Citations

14

H-Index

2005

Active since

Affiliations

University of Turin(Current)

New York University

University of Milan

Institute of Oncology Research

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Elisa Pellegrino is an author at University of Turin specializing in medicine, tumor biology, and cell signaling.

ORCID

Top concepts

Publications per year

2005–2024

15

Publications

15

Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes

Roberto Piva, Elisa Pellegrino, Michela Mattioli et al. · Journal of Clinical Investigation · 2006 · 164 citations · Full text

, , +14

Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms

Roberto Piva, Luca Agnelli, Elisa Pellegrino et al. · Journal of Clinical Oncology · 2010 · 161 citations

Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas

Roberto Piva, Roberto Chiarle, Andrea D. Manazza et al. · Blood · 2005 · 128 citations · Full text

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts

Irene Scarfò, Elisa Pellegrino, Elisabetta Mereu et al. · Blood · 2015 · 109 citations · Full text

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

Luca Agnelli, Elisabetta Mereu, Elisa Pellegrino et al. · Blood · 2012 · 107 citations · Full text

Rows per page

1–5 of 15